BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9713995)

  • 21. Transcriptional regulatory networks downstream of TAL1/SCL in T-cell acute lymphoblastic leukemia.
    Palomero T; Odom DT; O'Neil J; Ferrando AA; Margolin A; Neuberg DS; Winter SS; Larson RS; Li W; Liu XS; Young RA; Look AT
    Blood; 2006 Aug; 108(3):986-92. PubMed ID: 16621969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. c-tal, a helix-loop-helix protein, is juxtaposed to the T-cell receptor-beta chain gene by a reciprocal chromosomal translocation: t(1;7)(p32;q35).
    Fitzgerald TJ; Neale GA; Raimondi SC; Goorha RM
    Blood; 1991 Nov; 78(10):2686-95. PubMed ID: 1824262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TAL1, TAL2 and LYL1: a family of basic helix-loop-helix proteins implicated in T cell acute leukaemia.
    Baer R
    Semin Cancer Biol; 1993 Dec; 4(6):341-7. PubMed ID: 8142619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of BCL6 in chromosomal aberrations affecting band 3q27 in B-cell non-Hodgkin lymphoma.
    Chaganti SR; Chen W; Parsa N; Offit K; Louie DC; Dalla-Favera R; Chaganti RS
    Genes Chromosomes Cancer; 1998 Dec; 23(4):323-7. PubMed ID: 9824205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A third tal-1 promoter is specifically used in human T cell leukemias.
    Bernard O; Azogui O; Lecointe N; Mugneret F; Berger R; Larsen CJ; Mathieu-Mahul D
    J Exp Med; 1992 Oct; 176(4):919-25. PubMed ID: 1402666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T-cell acute lymphoblastic leukemia and the associated basic helix-loop-helix gene SCL/tal.
    Goldfarb AN; Greenberg JM
    Leuk Lymphoma; 1994 Jan; 12(3-4):157-66. PubMed ID: 8167548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of translocation t(1;14)(p32;q11) in a T and in a B acute leukemia.
    Bernard O; Barin C; Charrin C; Mathieu-Mahul D; Berger R
    Leukemia; 1993 Oct; 7(10):1509-13. PubMed ID: 8412312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TAL1 and LIM-only proteins synergistically induce retinaldehyde dehydrogenase 2 expression in T-cell acute lymphoblastic leukemia by acting as cofactors for GATA3.
    Ono Y; Fukuhara N; Yoshie O
    Mol Cell Biol; 1998 Dec; 18(12):6939-50. PubMed ID: 9819382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of the putative hematopoietic transcription factor SCL in T-cell acute lymphoblastic leukemia.
    Aplan PD; Lombardi DP; Reaman GH; Sather HN; Hammond GD; Kirsch IR
    Blood; 1992 Mar; 79(5):1327-33. PubMed ID: 1311214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. V(D)J-mediated translocations in lymphoid neoplasms: a functional assessment of genomic instability by cryptic sites.
    Marculescu R; Le T; Simon P; Jaeger U; Nadel B
    J Exp Med; 2002 Jan; 195(1):85-98. PubMed ID: 11781368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TAL1 gene deletions and TAL1 protein expression in sporadic melanoma.
    Chetty R; Cerroni L; Pulford K; Giatromanolaki A; Biddolph S; Kaklamanis L; Gatter K
    Melanoma Res; 1995 Aug; 5(4):251-4. PubMed ID: 7496160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of TAL1 gene alteration in childhood T-cell acute lymphoblastic leukemia and lymphoma.
    Kikuchi A; Hayashi Y; Kobayashi S; Hanada R; Moriwaki K; Yamamoto K; Fujimoto J; Kaneko Y; Yamamori S
    Leukemia; 1993 Jul; 7(7):933-8. PubMed ID: 8321044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coding sequences of the tal-1 gene are disrupted by chromosome translocation in human T cell leukemia.
    Chen Q; Yang CY; Tsan JT; Xia Y; Ragab AH; Peiper SC; Carroll A; Baer R
    J Exp Med; 1990 Nov; 172(5):1403-8. PubMed ID: 2230650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of the V(D)J recombination efficiency at lymphoid chromosomal translocation breakpoints.
    Raghavan SC; Kirsch IR; Lieber MR
    J Biol Chem; 2001 Aug; 276(31):29126-33. PubMed ID: 11390401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Helix-loop-helix (E2-5, HEB, TAL1 and Id1) protein interaction with the TCRalphadelta enhancers.
    Bernard M; Delabesse E; Smit L; Millien C; Kirsch IR; Strominger JL; Macintyre EA
    Int Immunol; 1998 Oct; 10(10):1539-49. PubMed ID: 9796921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The basic helix-loop-helix transcription factor TAL1/SCL inhibits the expression of the p16INK4A and pTalpha genes.
    Hansson A; Manetopoulos C; Jönsson JI; Axelson H
    Biochem Biophys Res Commun; 2003 Dec; 312(4):1073-81. PubMed ID: 14651981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia.
    Ferrando AA; Neuberg DS; Staunton J; Loh ML; Huard C; Raimondi SC; Behm FG; Pui CH; Downing JR; Gilliland DG; Lander ES; Golub TR; Look AT
    Cancer Cell; 2002 Feb; 1(1):75-87. PubMed ID: 12086890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular characterization of a new recombination of the SIL/TAL-1 locus in a child with T-cell acute lymphoblastic leukaemia.
    Carlotti E; Pettenella F; Amaru R; Slater S; Lister TA; Barbui T; Basso G; Cazzaniga G; Rambaldi A; Biondi A
    Br J Haematol; 2002 Sep; 118(4):1011-8. PubMed ID: 12199779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SIL-TAL1 deletion in T-cell acute lymphoblastic leukemia.
    Janssen JW; Ludwig WD; Sterry W; Bartram CR
    Leukemia; 1993 Aug; 7(8):1204-10. PubMed ID: 8350619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of super-enhancer-driven TAL1 expression by KLF4 in T-cell acute lymphoblastic leukemia.
    Noura M; Matsuo H; Yasuda T; Tsuzuki S; Kiyoi H; Hayakawa F
    Oncogene; 2024 Feb; 43(6):447-456. PubMed ID: 38102337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.